Davidenko J M, Cohen L, Goodrow R, Antzelevitch C
Masonic Medical Research Laboratory, Utica, New York 13504.
Circulation. 1989 Mar;79(3):674-86. doi: 10.1161/01.cir.79.3.674.
Early afterdepolarization (EAD)-induced triggered activity is thought to contribute to the cardiac arrhythmogenic effects of several class I antiarrhythmic agents. The combination of quinidine therapy, bradycardia, and hypokalemia is known to predispose to torsade de pointes, which is a form of atypical polymorphous ventricular tachycardia commonly associated with long QT intervals. Recent clinical reports have shown suppression of quinidine-induced torsade de pointes with intravenous administration of magnesium sulfate. To provide further understanding of these relations, we used standard microelectrode techniques to examine the time course of quinidine-induced action potential prolongation, EAD, and triggered activity development and the dependence of these changes on [K+]0, [Mg2+]0, and stimulation frequency in isolated Purkinje fiber preparations exposed to low concentrations of the drug. At slow stimulation rates, the quinidine-induced increase of action potential duration was slow to develop and failed to reach a steady state after 3 hours of exposure to the drug. EAD and EAD-induced triggered activity generally became apparent 70-90 minutes after adding the drug. Quinidine produced triggered activity in 10 of 22 preparations superfused with Tyrode's solution containing normal [K+]0 (3.5-4.0 mM) and in six other preparations when [K+]0 was reduced. In the presence of normal [K+]0, two types of EAD and triggered activity were distinguished. In four of 10 preparations, this activity arose from phase 2 of the action potential; in eight of 10, it was associated with phase 3; and in two experiments, both types were present in the same preparation. The incidence of both forms of triggered responses depended greatly on the rate of stimulation. Triggered activity arising from phase 3 was always manifest at rates considerably slower than those giving rise to phase 2 activity. Both forms of triggered activity were sensitive to changes in the extracellular concentration of potassium and magnesium. Lower-than-normal levels of these electrolytes facilitated the manifestation of triggered activity, whereas elevated levels suppressed or caused a shift in the frequency-dependence of the activity. Phase 2, but not phase 3, EADs were abolished in response to increased [Mg2+]0. The data show a clear congruity between the conditions that predispose to torsade de pointes in the clinic and the conditions under which quinidine may induce triggered activity and marked action potential prolongation in isolated Purkinje fibers.(ABSTRACT TRUNCATED AT 400 WORDS)
早期后除极(EAD)诱导的触发活动被认为与几种I类抗心律失常药物的致心律失常作用有关。已知奎尼丁治疗、心动过缓和低钾血症的联合易引发尖端扭转型室速,这是一种非典型多形性室性心动过速,通常与长QT间期相关。最近的临床报告显示,静脉注射硫酸镁可抑制奎尼丁诱导的尖端扭转型室速。为了进一步理解这些关系,我们使用标准微电极技术,研究了奎尼丁诱导的动作电位延长、EAD以及触发活动发展的时间进程,以及这些变化对暴露于低浓度药物的离体浦肯野纤维标本中[K+]0、[Mg2+]0和刺激频率的依赖性。在缓慢刺激速率下,奎尼丁诱导的动作电位持续时间增加发展缓慢,在暴露于药物3小时后未达到稳态。EAD和EAD诱导的触发活动通常在加入药物后70 - 90分钟变得明显。在22个用含正常[K+]0(3.5 - 4.0 mM)的台氏液灌流的标本中,有10个出现了奎尼丁诱导的触发活动,当[K+]0降低时,另外6个标本也出现了这种活动。在正常[K+]0存在的情况下,区分出了两种类型的EAD和触发活动。在10个标本中的4个,这种活动起源于动作电位的2期;在10个标本中的8个,与3期相关;在两个实验中同一标本中两种类型都存在。两种形式的触发反应发生率在很大程度上取决于刺激速率。起源于3期的触发活动总是在比引发2期活动的速率慢得多的速率下表现出来。两种形式的触发活动对细胞外钾和镁浓度的变化都很敏感。这些电解质低于正常水平会促进触发活动的表现,而升高水平则会抑制或导致活动频率依赖性的改变。增加[Mg2+]0可消除2期而非3期的EAD。数据表明,临床上易引发尖端扭转型室速的情况与奎尼丁在离体浦肯野纤维中可能诱导触发活动和显著动作电位延长的情况之间存在明显的一致性。(摘要截短至400字)